SCHEMBL30947045

SCHEMBL30947045

CC(C)(C)OC(=O)NCC(Cn1ncn(-c2ccc(F)c(F)c2)c1=O)=C(F)F

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PPARD Q03181 17/20 0.39
▸ PPARA Q07869 17/20 0.39
▸ PPARG P37231 11/20 0.37
▸ MMP13 P45452 1/20 0.36
▸ MMP14 P50281 1/20 0.36
▸ ADAM17 P78536 1/20 0.36
▸ ADAMTS5 Q9UNA0 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22091380 1.00 PPARD (0.39) PPARDPPARAPPARGMMP13MMP14
SCHEMBL30947259 0.92 PPARD (0.37) PPARDPPARAPPARG
SCHEMBL22091356 0.92 PPARD (0.37) PPARDPPARAPPARG
SCHEMBL22091253 0.89 PPARD (0.45) PPARDPPARAPPARG
SCHEMBL29981938 0.86 PPARD (0.38) PPARDPPARAPPARGMMP13MMP14
SCHEMBL29093193 0.86 PPARD (0.38) PPARDPPARAPPARGMMP13MMP14
SCHEMBL29092900 0.86 PPARD (0.38) PPARDPPARAPPARGMMP13MMP14
SCHEMBL29092901 0.86 PPARD (0.38) PPARDPPARAPPARGMMP13MMP14
SCHEMBL29981915 0.86 PPARD (0.38) PPARDPPARAPPARGMMP13MMP14
SCHEMBL22091102 0.85 EGFR (0.39) PPARDPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118894816-A 3, 3-Difluoroallylamine or salt thereof and pharmaceutical composition comprising the same 柳韩洋行 2024-11-05 — — CN disclosed
CN-113330001-B 3, 3-Difluoroallylamine or salt thereof and pharmaceutical composition comprising the same 柳韩洋行 2024-07-02 — — CN disclosed
Send feedback